Clinical trials of spinal injury repair drugs planned for humans

DRUGS with the potential to help people with spinal injuries regain use of their limbs could soon be tested on human patients.

The two antibodies block the action of a protein called Nogo that stops severed nerves sprouting new connections.

In experiments they have already helped rats with damaged spinal cords to walk again.